openPR Logo
Press release

Movement Disorder Market: Highlighting Regional Revenue Share Dominance During 2017 to 2022 | Key Players - Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation and Mayo Clinic.

02-22-2019 01:18 PM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

A substantial growth has been witnessed in new diagnostic information, neurosurgical and pharmacological treatments for movement disorder and assimilation of impaired motor control function. The spectrum of movement disorders such as Parkinson disease (PD), Chorea & Huntington’s disease, Ataxia and dystonia, namely, have been plaguing patients— impacting their ability to live independently. There have been several instances of co-existence of depression and desolation and other mental problems. Accordingly, treatments such as botulinum toxin injection, medications, surgical procedures and occupational and physical therapy such as deep brain stimulation to control motor symptoms have gained momentum.

Get Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=329

FDA approved medications and treatments have had positive influence in the market for movement disorder. Lately, the federal Food & Drug Administration gave nod to a scalpel-free treatment in patients with medication-resistant Parkinson’s disease. The procedure—focused ultrasound—leverages doctors to perform brain surgery without cutting into skull. Besides, FDA also approved Xadago (safinamide) tablets and Ingrezza capsules. The former is meant for the treatment of Parkinson’s disease, while latter is mean for the treatment of dyskinesia. Not long ago, FDA also approved a technology for treating essential tremor, a movement disorder bedeviling millions of Americans.

In a bid to gain competitive edge, manufacturers are heavily focusing on innovations and product development. Furthermore, manufacturers look to integrate sophisticated technological developments on the back of rising demand for quick recovery and enhanced results. Accordingly, technologically-influenced fork, spork, soup spoons and everyday spoon.

Movement Disorder Market: Overview

The report moots a comprehensive analysis on the market for movement disorder for the assessment period 2018-2026. The report also delves into the dynamics surrounding the movement disorder which significantly influence the growth of the market.

Furthermore, the report elucidates the segregation of the market which is anticipated to provide readers with an actionable insights which will aid them in taking proper decision based on segments historical and future growth estimates.

BROWSE Full Report NOW @ https://www.factmr.com/report/329/movement-disorder-market

The report focuses on cost structure and supply chain to provide a comprehensive view of the movement disorder market. The report also includes disease epidemiology and technology roadmap along with product lifecycle. Further, PESTLE analysis gives overall picture of the movement disorder market. The report provides a coherent assessment through average pricing analysis. The report also includes regional and country-wise assessment.

A qualitative and quantitative information has been obtained for the forecast and assessment on the movement disorder market. The research sources include primary and secondary sources which have been further examined by in-house panel of experts. The growth of end use industries in the historical and forecast period have been estimated to aid the readers with their business investment decisions. The market size of the movement disorder is the result of revenue comparison, market share comparison and Y-o-Y growth comparison on the geography.

Movement Disorder Market: Competitive Landscape

Major market players being instrumental for the growth of the movement disorder market are profiled and assessed on the basis of company overview, financial overview, product offering, recent development, key differentiators and strategies. The report also includes SWOT analysis to provide a holistic picture of the competitive scenario of the movement disorder market. A deep dive analysis of the major market players becomes indispensable as it will succor readers to make proper decision to enlarge their business and can comprehend strategic moves made by prominent players in the movement disorder market.

Enquire about this Report @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=329

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us            
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Movement Disorder Market: Highlighting Regional Revenue Share Dominance During 2017 to 2022 | Key Players - Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation and Mayo Clinic. here

News-ID: 1610419 • Views:

More Releases from Fact.MR

Triple Negative Breast Cancer Treatment Market is Growing at a CAGR of 4.6% by 2034 | Key players: Pfizer Inc., F. Hoffman-La Roche Ltd., Sanofi S.A., and Seattle Genetics, and Genentech.
10-03-2025 | Health & Medicine
Fact.MR
Triple Negative Breast Cancer Treatment Market is Growing at a CAGR of 4.6% by 2 …
Fact.MR today unveiled its latest report on the Triple Negative Breast Cancer Treatment Market, projecting steady yet impactful growth amid rising global breast cancer incidences and a push for innovative therapies targeting this aggressive subtype. Valued at USD 670.5 million in 2024, the global market is forecasted to expand at a compound annual growth rate (CAGR) of 4.6%, reaching USD 1.04 billion by 2034. This expansion underscores the urgent need
Pulmonary Fibrosis Treatment Market: U.S. to Grow to US$ 4.06 Billion by 2034, Led by Roche, Boehringer Ingelheim & Others
10-03-2025 | Health & Medicine
Fact.MR
Pulmonary Fibrosis Treatment Market: U.S. to Grow to US$ 4.06 Billion by 2034, L …
The global pulmonary fibrosis treatment market is poised for steady expansion, with its valuation projected to grow from USD 3,210 million in 2025 to USD 5,890 million by 2035. This growth reflects a compound annual growth rate (CAGR) of 6.2% over the forecast period from 2025 to 2035. The surge is primarily driven by the increasing prevalence of idiopathic pulmonary fibrosis (IPF), rising awareness of early diagnosis, and advancements in
Spices and Seasonings Market is Projected to Reach USD 23.6 Billion by 2035 | McCormick & Company, Associated British Foods, Olam International, Sensient Technologies, Kerry Group
10-03-2025 | Food & Beverage
Fact.MR
Spices and Seasonings Market is Projected to Reach USD 23.6 Billion by 2035 | Mc …
The global spices and seasonings market is set for significant growth, projected to expand from USD 14.5 billion in 2025 to USD 23.6 billion by 2035, achieving an absolute increase of USD 8.3 billion and a 57.2% overall growth. This trajectory reflects a compound annual growth rate (CAGR) of 5.0% over the forecast period from 2025 to 2035, representing a 1.57X market size increase. The expansion is driven by rising
Accounting Services Market: U.S. to Grow to US$ 640.73 Billion by 2034 at 10.3% CAGR, Supported by PwC, EY, Deloitte & KPMG
Accounting Services Market: U.S. to Grow to US$ 640.73 Billion by 2034 at 10.3% …
The global accounting services market is positioned for substantial growth, with its valuation projected to increase from USD 650 billion in 2025 to USD 1,250 billion by 2035. This expansion reflects a compound annual growth rate (CAGR) of 6.7% over the forecast period from 2025 to 2035. The market's surge is driven by the increasing complexity of financial regulations, the digital transformation of businesses, and the rising demand for outsourced

All 5 Releases


More Releases for Parkinson

Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025? The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period? The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market? In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market? In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $1.43 billion
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%. Increasing Geriatric Population Driving Demand: The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,